End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.88 CNY | -0.94% | +0.25% | -6.75% |
Apr. 25 | Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 12 | Byhealth Co., Ltd Approves Cash Dividend for the Year 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.75% | 3.74B | D | ||
+16.80% | 8.43B | D+ | ||
+7.94% | 7.8B | C- | ||
+15.02% | 6.82B | - | ||
-4.77% | 3.77B | B- | ||
+4.41% | 1.44B | - | - | |
-30.34% | 1.06B | B+ | ||
+20.28% | 1.04B | - | ||
-12.85% | 890M | C+ | ||
-15.63% | 812M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300146 Stock
- Ratings Byhealth Co., Ltd